INJE University PharmacoGenomics Research Center

Publications

Projects :
Published Dates :
Select All
Rifampin induces expression of P-glycoprotein on the macrophages, causing decrease intra-macrophage concentration of prothionamide (cPMTb)
J Pharm Sci. 108(9):3106-3111 / 2019.09 [LINK]
Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications (cPMTb)
Int J Mol Sci. 20(17):4274 / 2019.08 [LINK]
Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test (cPMTb)
Transl Clin Pharmacol. 27(2):64-68 / 2019.06 [LINK]
Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4 (cPMTb)
Drug Metab Pharmacokinet.34(3):201-208 / 2019.06 [LINK]
Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions with Ethionamide Involving Impact of Genetic Polymorphism on FMO3 (cPMTb)
J Clin Pharmacol. 59(6):880-889 / 2019.06 [LINK]
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (cPMTb)
Drug Des Devel Ther. 13:13:1623-1632/ 2019.05 [LINK]
Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine (cPMTb)
Br J Clin Pharmacol. 85(4):737-745 / 2019.04 [LINK]
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects (cPMTb)
Drug Des Devel Ther. 3:13:991-997 / 2019.04 [LINK]
Inhibition of cytochrome P450 activities by Sophora flavescens extract and its prenylated flavonoids in human liver microsomes (cPMTb)
Evid Based Complement Alternat Med. 13:2019:2673769 / 2019.03 [LINK]
10-Phenyltriazoyl artemisinin is a novel P-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein. (cPMTb)
Curr Pharm Des. 24(46):5590-5597 / 2019.02 [LINK]